Profile data is unavailable for this security.
About the company
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
- Revenue in USD (TTM)2.90bn
- Net income in USD467.20m
- Incorporated1923
- Employees10.60k
- LocationWest Pharmaceutical Services Inc530 Herman O. West DriveEXTON 19341United StatesUSA
- Phone+1 (610) 594-2900
- Fax+1 (800) 345-9800
- Websitehttps://www.westpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Henry Schein Inc | 12.67bn | 407.00m | 9.31bn | 25.00k | 23.15 | 2.75 | 13.36 | 0.7349 | 3.22 | 3.22 | 100.12 | 27.08 | 1.23 | 4.91 | 7.86 | 506,760.00 | 3.88 | 5.43 | 6.38 | 9.19 | 31.60 | 30.23 | 3.16 | 3.98 | 0.7525 | 6.94 | 0.3799 | 0.00 | 2.71 | 4.88 | -6.25 | -11.06 | 19.66 | -- |
| Avantor Inc | 6.69bn | 715.60m | 9.47bn | 13.50k | 13.23 | 1.55 | 8.44 | 1.42 | 1.05 | 1.05 | 9.80 | 8.95 | 0.5329 | 5.69 | 6.01 | 495,200.00 | 5.70 | 3.94 | 6.62 | 4.48 | 33.56 | 33.76 | 10.70 | 6.87 | 0.7532 | 3.95 | 0.4024 | 0.00 | -2.64 | 2.35 | 121.58 | -- | 23.59 | -- |
| Penumbra Inc | 1.24bn | 42.23m | 9.67bn | 4.50k | 243.44 | 7.97 | 152.47 | 7.80 | 1.03 | 1.03 | 31.38 | 31.35 | 0.7816 | 1.02 | 6.89 | 275,577.80 | 2.66 | 1.42 | 2.95 | 1.58 | 66.37 | 63.21 | 3.41 | 1.96 | 3.68 | -- | 0.019 | 0.00 | 12.86 | 16.89 | -84.59 | -21.98 | -0.853 | -- |
| Revvity Inc | 2.77bn | 296.04m | 11.89bn | 11.00k | 41.67 | 1.58 | 16.67 | 4.29 | 2.42 | 2.35 | 22.70 | 63.96 | 0.2148 | 3.05 | 4.59 | 251,806.20 | 2.30 | 4.31 | 2.49 | 4.84 | 56.25 | 58.50 | 10.69 | 15.78 | 2.99 | 14.59 | 0.2932 | 6.52 | 0.162 | -0.9086 | 57.70 | 4.20 | 1.27 | 4.56 |
| Solventum Corp | 8.31bn | 379.00m | 13.54bn | 22.00k | 35.96 | 4.15 | 14.67 | 1.63 | 2.18 | 2.18 | 47.69 | 18.85 | 0.5683 | 4.26 | 7.74 | 377,636.40 | 2.59 | -- | 3.05 | -- | 54.71 | -- | 4.55 | -- | 0.8523 | 1.93 | 0.7081 | -- | 0.6954 | -- | -64.41 | -- | -- | -- |
| Align Technology Inc | 3.98bn | 409.56m | 14.28bn | 20.95k | 35.85 | 3.79 | 25.46 | 3.59 | 5.49 | 5.49 | 53.41 | 51.94 | 0.6495 | 4.55 | 3.96 | 190,061.70 | 6.68 | 13.90 | 9.94 | 20.50 | 69.92 | 71.24 | 10.29 | 20.95 | 1.08 | -- | 0.00 | 0.00 | 3.54 | 10.69 | -5.32 | -0.9865 | -5.04 | -- |
| Hologic Inc | 4.03bn | 556.70m | 14.55bn | 7.06k | 27.57 | 3.15 | 17.04 | 3.61 | 2.37 | 2.37 | 17.31 | 20.73 | 0.4666 | 2.57 | 6.24 | 570,083.60 | 6.45 | 13.12 | 7.27 | 15.20 | 56.44 | 60.82 | 13.83 | 24.75 | 2.52 | 110.53 | 0.354 | 0.00 | -0.0025 | 3.66 | 73.14 | -- | 4.30 | -- |
| Cooper Companies Inc | 3.99bn | 414.20m | 14.57bn | 16.00k | 35.40 | 1.76 | 18.73 | 3.65 | 2.06 | 2.06 | 19.86 | 41.54 | 0.3261 | 1.58 | 5.43 | 249,262.50 | 3.39 | 8.72 | 3.68 | 9.73 | 67.20 | 65.70 | 10.39 | 26.35 | 1.23 | 6.80 | 0.2378 | 0.282 | 8.41 | 7.98 | 33.34 | -3.17 | 7.59 | -- |
| Illumina Inc | 4.34bn | -965.00m | 15.88bn | 8.97k | -- | 6.74 | -- | 3.66 | -6.10 | -6.10 | 27.23 | 14.89 | 0.5347 | 2.60 | 6.36 | 483,500.60 | -11.90 | -10.33 | -14.50 | -12.15 | 66.34 | 65.65 | -22.25 | -25.30 | 1.48 | 17.30 | 0.4566 | -- | -2.93 | 4.29 | -5.34 | -- | -9.34 | -- |
| West Pharmaceutical Services Inc | 2.90bn | 467.20m | 15.89bn | 10.60k | 34.75 | 5.92 | 25.92 | 5.49 | 6.37 | 6.37 | 39.47 | 37.37 | 0.8021 | 4.63 | 5.30 | 273,188.70 | 12.56 | 15.61 | 15.00 | 18.70 | 34.54 | 38.00 | 15.66 | 18.84 | 2.03 | -- | 0.0716 | 10.20 | -1.92 | 9.48 | -16.97 | 15.31 | 24.43 | 5.84 |
| Baxter International Inc | 10.77bn | -277.00m | 15.98bn | 38.00k | -- | 2.26 | 22.66 | 1.48 | -0.5388 | -1.10 | 21.03 | 13.80 | 0.4388 | 2.64 | 5.04 | 283,447.40 | -1.09 | -0.8441 | -1.37 | -1.03 | 36.73 | 38.63 | -2.49 | -2.03 | 1.40 | 3.65 | 0.5882 | -- | 2.66 | -1.31 | -293.68 | -- | -8.52 | 4.12 |
| Zimmer Biomet Holdings Inc | 7.70bn | 913.40m | 18.50bn | 17.00k | 20.72 | 1.49 | 9.60 | 2.40 | 4.51 | 4.51 | 38.06 | 62.63 | 0.3529 | 0.9622 | 5.17 | 452,852.90 | 4.19 | 2.34 | 4.75 | 2.68 | 71.05 | 71.18 | 11.88 | 7.60 | 1.46 | 6.46 | 0.3665 | 37.52 | 3.85 | -0.7725 | -11.74 | 2.05 | -3.69 | 0.00 |
| Waters Corp | 2.98bn | 657.02m | 20.94bn | 7.60k | 31.94 | 10.67 | 24.61 | 7.02 | 11.02 | 11.02 | 50.04 | 32.98 | 0.6556 | 2.31 | 4.45 | 392,533.30 | 14.44 | 18.41 | 18.02 | 23.46 | 59.27 | 58.71 | 22.02 | 22.81 | 1.28 | 13.77 | 0.426 | 0.00 | 0.0667 | 4.22 | -0.6851 | 1.61 | -2.75 | -- |
| Insulet Corp | 2.20bn | 402.20m | 21.22bn | 3.90k | 54.28 | 15.95 | 43.68 | 9.65 | 5.56 | 5.56 | 29.72 | 18.91 | 0.7161 | 1.49 | 6.08 | 563,820.50 | 13.10 | 6.00 | 15.50 | 7.03 | 70.39 | 67.05 | 18.29 | 9.22 | 3.63 | 49.39 | 0.5603 | 0.00 | 22.07 | 22.92 | 102.76 | 104.84 | -4.75 | -- |
Data as of Jul 03 2025. Currency figures normalised to West Pharmaceutical Services Inc's reporting currency: US Dollar USD
42.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2025 | 8.89m | 12.30% |
| BlackRock Fund Advisorsas of 31 Mar 2025 | 4.15m | 5.73% |
| SSgA Funds Management, Inc.as of 31 Mar 2025 | 3.20m | 4.43% |
| Brown Advisory LLCas of 31 Mar 2025 | 3.16m | 4.37% |
| Walter Scott & Partners Ltd.as of 31 Mar 2025 | 2.83m | 3.91% |
| Artisan Partners LPas of 31 Mar 2025 | 2.20m | 3.04% |
| Geode Capital Management LLCas of 31 Mar 2025 | 1.85m | 2.56% |
| Durable Capital Partners LPas of 31 Mar 2025 | 1.57m | 2.18% |
| APG Asset Management NVas of 31 Mar 2025 | 1.56m | 2.16% |
| Franklin Advisers, Inc.as of 31 Mar 2025 | 1.56m | 2.15% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
